Oura announced the launch of the Oura Ring 5 on Thursday, introducing a significantly smaller design and expanded health-monitoring capabilities.
The release marks a strategic move by the Finnish company to compete with larger wearables like the Apple Watch by offering a more traditional aesthetic. By shrinking the hardware while adding clinical-grade tracking, Oura aims to capture users who prefer discreet jewelry over wrist-based devices.
The Oura Ring 5 is 40% smaller than its predecessor [1]. The company said the device is the world's smallest smart ring [3]. This reduction in size is paired with a suite of new health features designed to provide a more comprehensive view of a user's physiological state.
Key additions include blood-pressure trend detection, and nighttime breathing analysis. These features may assist users in identifying signs of hypertension or sleep apnea. Additionally, the ring now includes GLP-1 medication tracking, allowing users to monitor the effects of specific weight-loss and diabetes medications on their health metrics.
While the company focused on the hardware improvements, some reports indicate the new model may come with a higher cost. There are reports of a potential price hike of up to $100 [2].
Oura's focus on smaller form factors reflects a broader industry trend toward "invisible" technology. By integrating blood-pressure signals and medication tracking into a ring, the company is attempting to bridge the gap between lifestyle accessories and medical diagnostic tools.
“The Oura Ring 5 is 40% smaller than its predecessor”
The integration of blood-pressure trends and GLP-1 tracking suggests a shift in the wearable market toward chronic disease management. By moving these capabilities from the wrist to a ring, Oura is positioning itself not just as a fitness tracker, but as a medical companion for users managing long-term health conditions.
